Advertisement
U.S. Markets close in 2 hrs 41 mins

KalVista Pharmaceuticals, Inc. (KALV)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
11.06-0.12 (-1.07%)
As of 01:18PM EST. Market open.
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Total Revenue
0
0
0
0
0
Operating Expense
147,115
131,993
95,086
81,310
57,923
Operating Income
-147,115
-131,993
-95,086
-81,310
-57,923
Net Non Operating Interest Income Expense
4,665
3,896
2,232
1,090
903
Other Income Expense
680
1,453
-53
-2,119
10,776
Pretax Income
-141,770
-126,644
-92,907
-82,339
-46,244
Tax Provision
-
0
0
0
0
Net Income Common Stockholders
-141,770
-126,644
-92,907
-82,339
-46,244
Diluted NI Available to Com Stockholders
-141,770
-126,644
-92,907
-82,339
-46,244
Basic EPS
-3.03
-3.44
-3.33
-3.36
-2.42
Diluted EPS
-3.03
-3.44
-3.33
-3.36
-2.42
Basic Average Shares
32,848
36,787
27,891
24,473
19,094
Diluted Average Shares
32,848
36,787
27,891
24,473
19,094
Total Operating Income as Reported
-155,567
-140,445
-110,871
-96,613
-57,923
Total Expenses
147,115
131,993
95,086
81,310
57,923
Net Income from Continuing & Discontinued Operation
-141,770
-126,644
-92,907
-82,339
-46,244
Normalized Income
-143,291
-128,107
-92,858
-80,221
-47,091
Interest Income
4,665
3,896
2,232
1,090
903
Net Interest Income
4,665
3,896
2,232
1,090
903
EBIT
-147,115
-131,993
-95,086
-81,310
-57,923
EBITDA
-146,268
-131,177
-94,368
-80,746
-57,386
Reconciled Depreciation
847
816
718
564
537
Net Income from Continuing Operation Net Minority Interest
-141,770
-126,644
-92,907
-82,339
-46,244
Total Unusual Items Excluding Goodwill
1,521
1,463
-49
-2,118
847
Total Unusual Items
1,521
1,463
-49
-2,118
847
Normalized EBITDA
-147,789
-132,640
-94,319
-78,628
-58,233
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0